Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether rifaximin alters gut bacterial flora after stem cell transplantation in patients with acute leukemia; currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifaximin (rifaximin)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Acute Leukemia | Phase 2 | Status: RECRUITING